Back

Prenosis recognized for AI-directed precision therapeutics platform

Verifying
  • Prenosis received a Chicago Innovation Award for its AI-directed precision therapeutics platform.
  • Sepsis ImmunoScore is the first FDA-authorized AI diagnostic for sepsis.
  • Prenosis will join 2025 award winners at Nasdaq's Opening Bell ceremony in New York City.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.